Journal of Bone and Joint Infection
Journal of Bone and Joint Infection
JBJI
Articles | Volume 6, issue 9
Articles | Volume 6, issue 9
https://doi.org/10.5194/jbji-6-413-2021
© Author(s) 2021. This work is distributed under
the Creative Commons Attribution 4.0 License.
https://doi.org/10.5194/jbji-6-413-2021
© Author(s) 2021. This work is distributed under
the Creative Commons Attribution 4.0 License.
Articles | Volume 6, issue 9
Original full-length article
 | 
12 Nov 2021
Original full-length article |  | 12 Nov 2021

Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: a multi-center study

Tom A. G. Van Vugt, Jeffrey Heidotting, Jacobus J. Arts, Joris J. W. Ploegmakers, Paul C. Jutte, and Jan A. P. Geurts

Viewed

Total article views: 1,577 (including HTML, PDF, and XML)
HTML PDF XML Total BibTeX EndNote
1,193 302 82 1,577 75 117
  • HTML: 1,193
  • PDF: 302
  • XML: 82
  • Total: 1,577
  • BibTeX: 75
  • EndNote: 117
Views and downloads (calculated since 12 Nov 2021)
Cumulative views and downloads (calculated since 12 Nov 2021)

Viewed (geographical distribution)

Total article views: 1,490 (including HTML, PDF, and XML) Thereof 1,490 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 
Latest update: 25 Nov 2025
Download
Short summary
Chronic osteomyelitis is a bone infection and was treated with a combination of antibiotics and two surgeries. With the introduction of the biomaterial S53P4 bioactive glass, these infections can be treated with antibiotics and one surgery. This study shows 85 % success in the treatment of these bone infections. Together with the fundamentally different antibacterial mechanisms without antibiotic resistance, S53P4 bioactive glass is recommendable for the treatment of these infections.
Read more
Share